Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Savara, Inc. - Common Stock (NQ:SVRA)

4.380 +0.080 (+1.86%)
Streaming Delayed Price Updated: 10:03 AM EDT, Oct 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Savara, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers 
Via Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Avidity Biosciences (NASDAQ:RNA) s... 
Via Benzinga
Savara to Present at the H.C. Wainwright BIOCONNECT Virtual Conference
From Savara Inc.
Via Business Wire
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders intereste... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Star Equity Hldgs (NASDAQ:STRR) s... 
Via Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
Savara to Participate in Two Upcoming Investor Healthcare Conferences
From Savara Inc.
Via Business Wire
Savara Reports Third Quarter 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara to Present at the Jefferies London Healthcare Conference
From Savara Inc.
Via Business Wire
Savara to Present at the Inaugural Piper Sandler Lung Day
From Savara Inc.
Via Business Wire
3 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
Savara to Participate in Two Upcoming Investor Healthcare Conferences
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
5 Penny Stocks Insiders Are Buying
When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Protagenic Therapeutics (NASDAQ:PTIX... 
Via Benzinga
Savara Reports Second Quarter 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
Savara Announces First Patient Dosed in Pivotal Phase 3 Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Trial
From Savara Inc.
Via Business Wire
Savara to Present at the Jefferies Virtual Healthcare Conference
From Savara Inc.
Via Business Wire
Savara to Present at the Oppenheimer Rare & Orphan Disease Virtual Summit
From Savara Inc.
Via Business Wire
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
From Savara Inc.
Via Business Wire
Savara Reports First Quarter 2021 Financial Results and Provides Business Update
From Savara Inc.
Via Business Wire
28 Stocks Moving in Wednesday's Pre-Market Session
Gainers Athenex, Inc. (NASDAQ: ATNX) shares rose 46.6% to $5.44 in pre-market trading after the company announced it acquired Kuur Therapeutics. iBio, Inc. (NYSE: IBIO) rose 29.5... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.